Financhill
Back

Aurinia Pharmaceuticals, Inc. Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

Aurinia Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 14.71 Sell
20-day SMA: 15.12 Sell
50-day SMA: 15.53 Sell
200-day SMA: 11.56 Buy
8-day EMA: 14.73 Sell
20-day EMA: 15.04 Sell
50-day EMA: 14.97 Sell
200-day EMA: 12.35 Buy

Aurinia Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 39.05 Sell
Chaikin Money Flow: 726914 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.75 - 15.91) Sell
Bollinger Bands (100): (12.27 - 15.79) Buy

Aurinia Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Aurinia Pharmaceuticals, Inc. Stock

Is Aurinia Pharmaceuticals, Inc. Stock a Buy?

AUPH Technical Analysis vs Fundamental Analysis

Buy
59
Aurinia Pharmaceuticals, Inc. (AUPH) is a Buy

Is Aurinia Pharmaceuticals, Inc. a Buy or a Sell?

Aurinia Pharmaceuticals, Inc. Stock Info

Market Cap:
1.9B
Price in USD:
14.57
Share Volume:
956.5K

Aurinia Pharmaceuticals, Inc. 52-Week Range

52-Week High:
16.54
52-Week Low:
6.55
Buy
59
Aurinia Pharmaceuticals, Inc. (AUPH) is a Buy

Aurinia Pharmaceuticals, Inc. Share Price Forecast

Is Aurinia Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Aurinia Pharmaceuticals, Inc.

Is Aurinia Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.14 per share.

Technical Analysis of Aurinia Pharmaceuticals, Inc.

Should I short Aurinia Pharmaceuticals, Inc. stock?

* Aurinia Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.